Rapporto sull’analisi delle quote e delle dimensioni del mercato dei farmaci siringhe preriempite | Previsioni 2031

  • Report Code : TIPRE00027665
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

PANORAMICA DEL MERCATO Una siringa preriempita è un contenitore monodose di farmaco per uso parenterale a cui è stato inserito un ago dal produttore. Riducendo il rischio di inserimento involontario dell'ago e di esposizione dannosa al prodotto che può verificarsi durante l'aspirazione del farmaco dalle fiale, le siringhe preriempite migliorano la sicurezza del paziente. Le siringhe preriempite forniscono farmaci a basso costo a casa e fanno risparmiare tempo nelle unità di cura ospedaliere e ambulatoriali. Rispetto a fiale e fiale, l’uso di molecole farmacologiche in siringa preriempita riduce il costo medio per iniezione per i pazienti che richiedono una somministrazione frequente di dosi su base settimanale e giornaliera. La somministrazione di farmaci tramite siringhe preriempite è preferita rispetto alle fiale convenzionali perché offre una serie di vantaggi, tra cui un riempimento eccessivo ridotto e una somministrazione sicura e conveniente, che sta aumentando la domanda di molecole farmacologiche tramite siringhe preriempite. AMBITO DI MERCATO Il mercato dei farmaci per siringhe preriempite è uno studio specializzato e approfondito del settore sanitario con particolare attenzione all'analisi delle tendenze del mercato globale. L’obiettivo del rapporto è fornire una panoramica del mercato Farmaci Siringhe Preriempite con una segmentazione completa del mercato per tipo, materiale, utente finale e area geografica. Il rapporto fornisce statistiche chiave sullo stato del mercato dei principali attori e offre le principali tendenze e opportunità del mercato Siringhe preriempite Drug. SEGMENTAZIONE DEL MERCATO
    • Sulla base della classe del farmaco, il mercato dei farmaci per siringhe preriempite è segmentato in: • Vaccini • Insulina • Adrenalina • Oppioidi •  Altri • Per applicazione, il mercato è segmentato in: • Malattie cardiovascolari • Diabete • Immunizzazione • Gestione del dolore • In base all'utente finale, il mercato dei farmaci per siringhe preriempite è segmentato in: •  Farmacie ospedaliere • Farmacie al dettaglio • Farmacie online • Negozi di farmaci
DINAMICHE DI MERCATO Driver:
    • La crescente prevalenza delle malattie croniche richiede ai pazienti di autosomministrarsi i farmaci. • Crescente adozione di dispositivi per l'autoiniezione da parte dei genitori. • Crescente domanda di siringhe preriempite. • Riduzione dei costi e migliore efficienza delle siringhe preriempite.
Restrizioni:
    • Adozione della tecnologia brevettata, con conseguente aumento dei costi di produzione.
Il rapporto fornisce una panoramica dettagliata del settore, comprese informazioni sia qualitative che quantitative. Fornisce una panoramica e previsioni del mercato globale in base a vari segmenti. Fornisce inoltre stime sulle dimensioni del mercato e sulle previsioni per l’anno dal 2021 al 2031 rispetto a cinque regioni principali, vale a dire; Nord America, Europa, Asia-Pacifico (APAC), Medio Oriente e Africa (MEA) e Sud America. Il mercato dei farmaci per siringhe preriempite in ciascuna regione è successivamente suddiviso in sottosegmenti in base ai rispettivi paesi e segmenti. Il rapporto copre l’analisi e le previsioni di 18 paesi a livello globale insieme alla tendenza attuale e alle opportunità prevalenti nella regione. Il rapporto analizza i fattori che influenzano il mercato sia dal lato della domanda che dell'offerta e valuta ulteriormente le dinamiche del mercato che influenzano il mercato durante il periodo di previsione, ovvero fattori trainanti, restrizioni, opportunità e tendenze future. Il rapporto fornisce anche un'analisi PEST esaustiva per tutte e cinque le regioni, vale a dire; Nord America, Europa, APAC, MEA e Sud America dopo aver valutato i fattori politici, economici, sociali e tecnologici che influenzano il mercato dei farmaci siringhe preriempite in queste regioni. IMPATTO DI COVID-19 SUL MERCATO DEI FARMACI DELLE SIRINGHE PRERIEMPITE Il COVID-19 è iniziato per la prima volta a Wuhan (Cina) nel dicembre 2021 e da allora si è diffuso rapidamente in tutto il mondo. Stati Uniti, India, Brasile, Russia, Francia, Regno Unito, Turchia, Italia e Spagna sono alcuni dei paesi più colpiti in termini di casi confermati e decessi segnalati. La pandemia ha influenzato la crescita di questo mercato in tutto il mondo a causa della chiusura delle attività, del blocco mondiale e delle interruzioni della fornitura e del commercio. ATTORI DI MERCATO Il rapporto copre gli sviluppi chiave nel mercato dei farmaci siringhe preriempite come strategie di crescita organica e inorganica. Diverse aziende si stanno concentrando su strategie di crescita organica come lanci di prodotti, approvazioni di prodotti e altri come brevetti ed eventi. Le attività di strategia di crescita inorganica testimoniate nel mercato sono state acquisizioni e partenariati Collaborazioni. Queste attività hanno aperto la strada all'espansione del business e della base clienti degli operatori del mercato. Si prevede che gli operatori del mercato dei farmaci siringhe preriempite avranno opportunità di crescita redditizie in futuro con la crescente domanda del mercato dei farmaci siringhe preriempite nel mercato globale. Il rapporto include anche i profili delle principali aziende insieme alla loro analisi SWOT e strategie di mercato nel mercato dei farmaci siringhe preriempite. Inoltre, il rapporto si concentra sui principali attori del settore con informazioni quali profili aziendali, componenti e servizi offerti, informazioni finanziarie degli ultimi 3 anni e lo sviluppo chiave degli ultimi cinque anni.
    • Amgen Inc. • Teva Pharmaceutical Industries Ltd. • AstraZeneca plc • Mylan NV • Pfizer, Inc. • Fresenius Kabi AG • Johnson & Johnson • Sanofi •Merck & Co.Inc. • Novartis AG
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region higesht CAGR the prefilled syringes drug market in 2023?

Asia Pacific region dominated the prefilled syringes drug market in 2023

Which are some of the major players operating in the market?

Amcor plc,3M,Sonoco Product, Berry Global,Sealed Air corporation,Dunmore Corporation,Mondi Group,Bio-rad Laboratories, CCL Industries

Which region dominated the prefilled syringes drug market in 2023?

North America region dominated the prefilled syringes drug market in 2023

What is the major trend inPrefilled Syringes Drug Market ?

Increasing scope of nucleic acid therapies

What are the driving factors impacting the prefilled syringes drug market ?

The major driving factors of prefilled syringes drug market are:

1. Increased cases of TB worldwide

2. Advances in Diagnostic Technologies

3. Igovernment initiatives and funding

What is the expected CAGR of the Prefilled Syringes Drug Market ?

The Prefilled Syringes Drug Market is estimated to witness a CAGR of 10.0% from 2023 to 2031

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

- Amgen Inc.
- Teva Pharmaceutical Industries Ltd.
- AstraZeneca plc
- Mylan N.V.
- Pfizer, Inc.
- Fresenius Kabi AG
- Johnson & Johnson
- Sanofi
- Merck & Co.Inc.
- Novartis AG

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.